Osteoporosis
Data demonstrate benefits of once-yearly Aclasta in postmenopausal osteoporosis
Published in Women's Health Weekly, October 19th, 2006
Benefits were shown across the most common fracture sites - hip, spine and nonspine - with the effect sustained over three years.
Further data demonstrated that PMO patients currently taking oral alendronate can be switched to Aclasta and maintain the beneficial bone effects for a full 12 months after a single dose.
Aclasta (zoledronic acid 5 mg solution for infusion) is the only once-yearly bisphosphonate...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Asthma
Asthma risk appears to be associated with body mass index and physical activity in women - Asthma
Sleep disorders appear to be associated with asthma and atopic syndrome in women - Breast Cancer
Breast cancer risk is increased in women with prenatal exposure to diethylstilbestrol - Colon Cancer
Incidence of colorectal polyps is inversely related to exercise in African-American women - Coronary Artery Disease
Heart disease in women may be related more to risk factors than education or job stress - Addiction Medicine
Hazelden unveils new Women's Recovery Center in Minnesota - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
